The company had posted a net profit of Rs 3.5 crore in the same quarter last fiscal, Hester Biosciences said in a BSE filing.
Standalone net sales of the company rose to Rs 28.18 crore for quarter under review as against Rs 23.36 crore in the year-ago period.
Also Read
Its standalone net sales for the fiscal increased to Rs 100.89 crore from Rs 90.03 crore in the preceding fiscal.
In a separate filing, Hester Biosciences said its Board of Directors has recommended a final dividend of Rs 1.10 per equity share for 2015-16 fiscal.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)